A decade of HPLC-MS/MS in the routine clinical laboratory - Goals for further developments

Clinical Biochemistry

Volumn 41, Issue 9, 2008, Pages 649-662

  Vogeser, Michael ^a   Seger, Christoph ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Institute of Medical Physics   (Austria)

Author keywords

Clinical toxicology; High performance liquid chromatography tandem mass spectrometry (HPLC MS MS); Metabolomics; Routine application; Therapeutic drug monitoring

Indexed keywords

XENOBIOTIC AGENT;

CLINICAL CHEMISTRY; CLINICAL LABORATORY; CLINICAL PHARMACOLOGY; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; LIGAND BINDING; MASS SPECTROMETRY; METABOLIC DISORDER; METABOLOMICS; MOLECULAR WEIGHT; PRIORITY JOURNAL; REVIEW; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLINICAL LABORATORY TECHNIQUES; GOALS; PHARMACEUTICAL PREPARATIONS; TANDEM MASS SPECTROMETRY;

EID: 43449083749     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.02.017     Document Type: Review

References (84)

1. de Hoffmann E. Tandem mass spectrometry: a primer. J Mass Spectrom 31 (1996) 129-137
2. Taylor P.J. High-performance liquid chromatography-mass spectrometry in the clinical laboratory. Ther Drug Monit 27 (2005) 689-693
3. Vogeser M. Liquid chromatography-tandem mass spectrometry - application in the clinical laboratory. Clin Chem Lab Med 41 (2003) 117-126
4. Bowers L.D. High-performance liquid chromatography/mass spectrometry: state of the art for the drug analysis laboratory. Clin Chem 35 (1989) 1282-1287
5. Covey T.R., Lee E.D., and Henion J.D. High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samples. Anal Chem 58 (1986) 2453-2460
6. Chace D.H., Millington D.S., Terada N., Kahler S.G., Roe C.R., and Hofman L.F. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 39 (1993) 66-71
7. Millington D.S., Kodo N., Terada N., Roe D., and Chace D.H. The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry. Int J Mass Spectrom 111 (1991) 211-228
8. Constanzer M., Chavez C., and Matuszewski B. Development and comparison of high-performance liquid chromatographic methods with tandem mass spectrometric and ultraviolet absorbance detection for the determination of cyclobenzaprine in human plasma and urine. J Chromatogr B 666 (1995) 117-126
9. Taylor P.J., Jones A., Balderson G.A., Lynch S.V., Norris R.L.G., and Pond S.M. Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. Clin Chem 42 (1996) 279-285
10. Rashed M.S., Bucknall M.P., Little D., et al. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin Chem 43 (1997) 1129-1141
11. Chace D.H., Kalas T.A., and Naylor E.W. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem 49 (2003) 1797-1817
12. Yang Z., Peng Y., and Wang S. Immunosuppressants: pharmacokinetics, methods of monitoring and role of high performance liquid chromatography/mass spectrometry. Clin Appl Immunol Rev 5 (2005) 405-430
13. Seger C., and Griesmacher A. Some important aspects of implementing tandem mass spectrometry in a routine clinical laboratory environment. Biochem Med 17 (2007) 29-51
14. Mauerer H.H. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 388 (2007) 1315-1325
15. Mauerer H.H. Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control. J Mass Spectrom 41 (2006) 1399-1413
16. Kamel A., and Prakash C. High performance liquid chromatography/atmospheric pressure ionization/tandem mass spectrometry (HPLC/API/MS/MS) in drug metabolism and toxicology. Curr Drug Metab 7 (2006) 837-852
17. Stokvis E., Rosing H., and Beijnen J.H. Liquid chromatography-mass spectrometry for the quantitative bioanalysis of anticancer drugs. Mass Spectrom Rev 24 (2005) 887-917
18. Baumann P., Hiemke C., Ulrich S., et al. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 37 (2004) 243-265
19. Vogeser M., and Parhofer K.G. Liquid chromatography tandem-mass spectrometry (LC-MS/MS) - technique and applications in endocrinology. Exp Clin Endocrinol Diabetes 115 (2007) 555-570
20. Bartolucci G., Pieraccini G., Villanelli F., Moneti G., and Triolo A. Liquid chromatography tandem mass spectrometric quantitation of sulfamethazine and its metabolites: direct analysis of swine urine by triple quadrupole and by ion trap mass spectrometry. Rapid Commun Mass Spectrom 14 (2000) 967-973
21. Guillarme D., Nguyen D.T.T., Rudaz S., and Veuthey J.L. Recent developments in liquid chromatography - impact on qualitative and quantitative performance. J Chromatogr A 1149 (2007) 20-29
22. Soler C., Hamilton B., Furey A., James K.J., Manes J., and Pico Y. Comparison of four mass analyzers for determining carbosulfan and its metabolites in citrus by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 20 (2006) 2151-2164
23. Annesley T.M. Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry. Clin Chem 53 (2007) 1827-1834
24. Napoli K.L. Organic solvents compromise performance of internal standard in proficiency testing of mass spectrometry-based assays for tacrolimus. Clin Chem 52 (2006) 765-766
25. Annesley T.M., and Clayton L. Simple extraction protocol for analysis of immunosuppressant drugs in whole blood. Clin Chem 50 (2004) 1845-1848
26. Nussbaumer K., Niederberger W., and Keller H.P. Determination of cyclosporin A in blood and plasma by column switching high-performance liquid chromatography after rapid sample preparation. J High Res Chromatogr 5 (1982) 424-427
27. Poquette M.A., Lensmeyer G.L., and Doran T.C. Effective use of liquid chromatography-mass spectrometry (LC/MS) in the routine clinical laboratory for monitoring sirolimus, tacrolimus, and cyclosporine. Ther Drug Monit 27 (2005) 144-150
28. Vogeser M., and Spöhrer U. Automated processing of whole blood samples for the determination of immunosuppressants by liquid chromatography tandem-mass spectrometry. Clin Chem Lab Med 44 (2006) 1126-1130
29. Koal T., Sibum M., Koster E., Resch K., and Kaever V. Direct and fast determination of antiretroviral drugs by automated online solid-phase extraction-liquid chromatography-tandem mass spectrometry in human plasma. Clin Chem Lab Med. 44 (2006) 299-305
30. de Jong W.H.A., Graham K.S., van der Molen J.C., et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC-tandem mass spectrometry. Clin Chem 53 (2007) 1684-1693
31. Taylor P.J. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 38 (2005) 328-334
32. Peters F.T., Drummer O.H., and Musshoff F. Validation of new methods. Forensic Sci Int 165 (2007) 216-224
33. Vogeser M., Zachoval R., Spohrer U., and Jacob K. Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther Drug Monit 23 (2001) 722-724
34. Vogeser M., and Spoehrer U. Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 43 (2005) 400-402
35. Vogeser M., and Schelling G. Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples. Clin Chem Lab Med 45 (2007) 1023-1025
36. Kushnir M.M., Rockwood A.L., Roberts W.L., et al. Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clin Chem 52 (2006) 120-128
37. Starka L. Epitestosterone. J Steroid Biochem 87 (2003) 27-34
38. Van de Kerkhof D.H., de Boer D., Thijssen J.H.H., and Maes R.A.A. Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysis. J Anal Toxicol 24 (2000) 105-112
39. Rauh M., Gröschl M., and Rascher W. Simultaneous quantification of ghrelin and desacyl-ghrelin by liquid chromatography-tandem mass spectrometry in plasma, serum, and cell supernatants. Clin Chem 53 (2007) 902-910
40. Bondar O.P., Barnidge D.R., Klee E.W., Davis B.J., and Klee G.G. LC-MS/MS quantification of Zn-a2 glycoprotein: a potential serum biomarker for prostate cancer. Clin Chem 53 (2007) 673-678
41. Kirsch S., Widart J., Louette J., Focant J.F., and de Pauw E. Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry. J Chromatogr A 1153 (2007) 300-306
42. Rodriguez-Cabaleiro D., Stockl D., Kaufman J.M., Fiers T., and Thienpont L.M. Feasibility of standardization of serum c-peptide immunoassays with isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 52 (2006) 1193-1196
43. Veenstra T.D. Global and targeted quantitative proteomics for biomarker discovery. J Chromatogr B 847 (2007) 3-11
44. Hortin G.L. A new era in protein quantification in clinical laboratories: application of liquid chromatography-tandem mass spectrometry. Clin Chem 53 (2007) 543-544
45. Lennard L. Therapeutic drug monitoring of cytotoxic drugs. Brit J Clin Pharmacol 52 (2001) 75S-87S
46. Widmer N., Decosterd L.A., Csajka C., et al. Population pharmacokinetics of imatinib and the role of a1-acid glycoprotein. Brit J Clin Pharmacol 62 (2006) 97-112
47. Back D.J., Khoo S.H., Gibbons S.E., and Merry C. The role of therapeutic drug monitoring in treatment of HIV infection. Brit J Clin Pharmacol 52 (2001) 89S-96S
48. Jen J.F., Glue P., Gupta S., Zambas D., and Hajian G. Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C. Ther Drug Monit 22 (2000) 555-565
49. Touw D.J., Neef C., Thomson A.H., and Vinks A.A. Cost-effectiveness of therapeutic drug monitoring: a systematic review. Ther Drug Monit 27 (2005) 10-17
50. Sauvage F.L., Saint-Marcoux F., Duretz B., Deporte D., Lachatre G., and Marquet P. Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clin Chem 52 (2006) 1735-1742
51. Gardiner S.J., and Begg E.J. Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?. Pharmacogenet Genom 15 (2005) 365-369
52. Gardiner S.J., and Begg E.J. Pharmacogenetics, drug-metabolizing enzymes, and clinical practice. Pharmacol Rev 58 (2006) 521-590
53. Wusk B., Kullak-Ublick G.A., Rammert C., von Eckardstein A., Fried M., and Rentsch K.M. Thiopurine S-methyltransferase polymorphisms: efficient screening method for patients considering taking thiopurine drugs. Eur J Clin Pharmacol 60 (2004) 5-10
54. Gearry R.B., Barclay M.L., Roberts R.L., et al. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice. Intern Med J 35 (2005) 580-585
55. Yin O.Q., Lam S.S., Lo C.M., and Chow M.S. Rapid determination of five probe drugs and their metabolites in human plasma and urine by liquid chromatography/tandem mass spectrometry: application to cytochrome P450 phenotyping studies. Rapid Commun Mass Spectrom 18 (2004) 2921-2933
56. Petrovic M., Eljarrat E., de Alda M.J., and Lopez B.D. Endocrine disrupting compounds and other emerging contaminants in the environment: a survey on new monitoring strategies and occurrence data. Anal Bioanal Chem 378 (2004) 549-562
57. th 2007
58. Barr D.B., Weihe P., Davis M.D., Needham L.L., and Grandjean P. Serum polychlorinated biphenyl and organochlorine insecticide concentrations in a Faroese birth cohort. Chemosphere 62 (2006) 1167-1182
59. Lee D.H., Lee I.K., Song K., et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the national health and examination survey 1999-2002. Diabetes Care 29 (2006) 1638-1644
60. Lee D.H., and Jacobs Jr. D.R. Association between serum concentrations of persistent organic pollutants and gamma-glutamyltransferase: results from the National Health and Examination Survey 1999-2002. Clin Chem 52 (2006) 1825-1827
61. Kielstein J.T., and Cooke J.P. Should we measure asymmetric dimethylarginine in patients with coronary artery disease?. Clin Chem 53 (2007) 161-163
62. Hu C.W., Wu M.T., Chao M.R., et al. Comparison of analyses of urinary 8-hydroxy-2′-deoxyguanosine by isotope-dilution liquid chromatography with electrospray tandem mass spectrometry and by enzyme-linked immunosorbent assay. Rapid Commun Mass Spectrom. 18 (2004) 505-510
63. Holleland G., Schneede J., Ueland P.M., Lund P.K., Refsum H., and Sandberg S. Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem 45 (1999) 189-198
64. Stover P.J. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 62 (2004) S3-S12
65. Nagpal K., Minocha V.R., Agrawal V., and Kapur S. Evaluation of intestinal mucosal permeability function in patients with acute pancreatitis. Am J Surg 192 (2006) 24-28
66. Harris W.S. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 55 (2007) 217-223
67. Griffiths W.J., Wang Y., Alvelius G., Liu S., Bodin K., and Sjovall J. Analysis of oxysterols by electrospray tandem mass spectrometry. J Am Soc Mass Spectrom 17 (2006) 341-362
68. Steinhart H., Rickert R., Winkler K., et al. Trans fatty acids and cardiovascular disease. N Engl J Med 354 (2006) 1601-1613
69. Steinhart H., Rickert R., and Winkler K. Trans fatty acids (TFA): analysis, occurrence, intake and clinical relevance. Eur J Med Res 20 (2003) 358-362
70. Brownlee M., Cerami A., and Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318 (1988) 1315-1321
71. Bidmon C., Frischmann M., and Pischetsrieder M. Analysis of DNA-bound advanced glycation end-products by LC and mass spectrometry. J Chromatogr B 855 (2007) 51-58
72. Schettgen T., Tings A., Brodowsky C., Muller-Lux A., Musiol A., and Kraus T. Simultaneous determination of the advanced glycation end product N (varepsilon)-carboxymethyllysine and its precursor, lysine, in exhaled breath condensate using isotope-dilution-hydrophilic-interaction liquid chromatography coupled to tandem mass spectrometry. Anal Bioanal Chem 387 (2007) 2783-2791
73. Lapolla A., Fedele D., Seraglia R., and Traldi P. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update. Mass Spectrom Rev 25 (2006) 775-797
74. Lapolla A., Basso E., and Traldi P. Mass spectrometry of advanced glycation end products. Adv Clin Chem 40 (2005) 165-217
75. Owen L.J., Wear J.E., and Keevil B.G. Validation of a liquid chromatography tandem mass spectrometry assay for serum creatinine and comparison with enzymatic and Jaffe methods. Ann Clin Biochem 43 (2006) 118-123
76. Willekens E., Thienpont L.M., Stockl D., Kobold U., Hölzel W., and de Leenheer A.P. Quantification of glycohemoglobin in blood by mass spectrometry applying multiple-reaction monitoring. Clin Chem 46 (2006) 281-283
77. Kobold U., Jeppsson J.O., Dulffer T., Finke A., Hoelzel W., and Miedema K. Candidate reference methods for hemoglobin A1c based on peptide mapping. Clin Chem 43 (1997) 1944-1951
78. Seger C., and Sturm S. Analytical aspects of plant metabolite profiling platforms: current standings and future aims. J Proteome Res 6 (2007) 480-497
79. Want E.J., Nordström A., Morita H., and Siuzdak G. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J Proteome Res 6 (2007) 459-468
80. Nicholson J.K., Holmes E., Lindon J.C., and Wilson I.D. The challenges of modeling mammalian biocomplexity. Nat Biotechnol 22 (2004) 1268-1274
81. Williams J., Wood J., Pandarinathan L., et al. Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Anal Chem 79 (2007) 5582-5593
82. Bleijerveld O.B., Houweling M., Thomas M.J., and Cui Z. Metabolipidomics: profiling metabolism of glycerophospholipid species by stable isotopic precursors and tandem mass spectrometry. Anal Biochem 352 (2006) 1-14
83. Lin Z.J., Li W., and Dai G. Application of LC-MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides. J Pharm Biomed Anal 44 (2007) 330-341
84. Anderson L., and Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 5 (2006) 573-588